Table 3. Clinical characteristics of patients with GLP-1RA-related hypoglycemia sourced from the FAERS database (from January 2004 to September 2020).
| Characteristics | Reports, No. (%) |
|---|---|
| Age | |
| <18 | 1 (0.09) |
| 18–44 | 72 (6.19) |
| 45–64 | 427 (36.68) |
| 65–74 | 214 (18.38) |
| 75–84 | 69 (5.93) |
| >84 | 14 (1.20) |
| Unknown | 367 (31.53) |
| Gender | |
| Female | 692 (59.45) |
| Male | 424 (36.43) |
| Unknown | 48 (4.12) |
| Area | |
| North America | 895 (76.89) |
| Europe | 121 (10.40) |
| Asia | 97 (8.33) |
| South America | 43 (3.69) |
| Oceania | 8 (0.69) |
| Reporter | |
| Consumer | 723 (62.11) |
| Physician | 254 (21.82) |
| Pharmacist | 52 (4.47) |
| Other health-professional | 79 (6.79) |
| Unknown | 56 (4.81) |
| Drugs | |
| Exenatide | 723 (62.11) |
| Liraglutide | 178 (15.29) |
| Albiglutide | 21 (1.80) |
| Dulaglutide | 207 (17.78) |
| Lixisenatide | 13 (1.12) |
| Semaglutide | 22 (1.89) |
| Indications | |
| Type 1 diabetes mellitus | 10 (0.86) |
| Type 2 diabetes mellitus | 534 (45.88) |
| Diabetes mellitus-unspecified | 334 (28.69) |
| Abnormal blood glucose | 18 (1.55) |
| Weight control | 19 (1.63) |
| Unknown | 249 (21.39) |
GLP-1RA, glucagon-like peptide-1 receptor agonist.